UNSPSC 41131802: Calibrator for cell indices

In this classification a calibrator for cell indices is a device that approximates whole blood or certain blood cells and that is used to set an instrument intended to measure mean cell volume (MCV), mean corpuscular hemoglobin (MCH), and mean corpuscular hemoglobin concentration (MCHC), or other cell indices US FDA regulates Calibrator for cell indices under 21 CFR 864.8150 and under FDA product code KRX.

UNSPSC 41131802 Calibrator for cell indices is a Commodity code capturing laboratory equipment and consumables that state and local public health agencies procure to operate diagnostic testing infrastructure. Recent activity shows state and local governments buying both clinical laboratory analyzers and their supporting culture media, reagents, and calibration supplies — equipment and materials necessary for hemoglobin testing, cell analysis, and other diagnostic screening. Issuing bodies are primarily state health departments and public health laboratories operating statewide infrastructure. The California Department of Public Health and the Texas Health and Human Services Commission / Department of State Health Services are repeat buyers, signaling sustained demand across large state health systems.

Recent opportunities cluster in California and Texas. The California Department of Public Health posted an RFB in August 2026 for public health laboratory supplies and media (RFBIS27200117, response due September 4, 2026) under CBE set-asides for small businesses, minority-owned enterprises, women-owned businesses, and disabled veteran-owned businesses; pricing is itemized and unit-based for each product line. The Texas Health and Human Services Commission issued an IFB in May 2026 (HHS0017310, response due May 18, 2026) for a D-10 Hemoglobin Testing System with Rack Loader to replace aging laboratory equipment at the South Texas Lab in Harlingen, with firm fixed pricing and no substitutions permitted; historical spending guidance for similar goods ranged from $45,050 to $80,000 in fiscal year 2025. Both solicitations emphasize technical specifications, quality standards, and compatibility with existing laboratory protocols, and both reserve discretion to award on best value rather than lowest price alone.